Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/31/2025

Bisoprolol Pharmacokinetics and Clinical Implications

Introduction to Bisoprolol

  • The European Society of Cardiology recommends bisoprolol for once-daily dosing due to its long half-life, which allows for 24-hour efficacy in angina treatment 1

Dosing Considerations

  • The American College of Cardiology suggests that when initiating bisoprolol in heart failure patients, the long half-life should be considered during dose titration, with dose adjustments made at not less than 2-week intervals 2
  • The European Journal of Heart Failure recommends considering the long half-life of bisoprolol when discontinuing the medication to avoid potential rebound effects 3

Comparison to Other Medications

  • The American College of Cardiology notes that bisoprolol's half-life (9-12 hours) is longer than metoprolol (3-7 hours) and propranolol (3-6 hours), but shorter than nadolol (20-24 hours) 4

Perioperative Considerations

  • The European Heart Journal suggests that when using bisoprolol for perioperative beta blockade, the long half-life should be considered when determining the timing of initiation before surgery 5
  • The American College of Cardiology recommends considering the long half-life of bisoprolol when using it for perioperative beta blockade, with timing of initiation determined accordingly 6